A detailed history of Harbor Capital Advisors, Inc. transactions in Haemonetics Corp stock. As of the latest transaction made, Harbor Capital Advisors, Inc. holds 56,164 shares of HAE stock, worth $4.97 Million. This represents 0.2% of its overall portfolio holdings.

Number of Shares
56,164
Previous 25,775 117.9%
Holding current value
$4.97 Million
Previous $2.13 Million 111.73%
% of portfolio
0.2%
Previous 0.16%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 29, 2024

BUY
$72.45 - $91.58 $2.2 Million - $2.78 Million
30,389 Added 117.9%
56,164 $4.51 Million
Q2 2024

Jul 09, 2024

BUY
$81.24 - $97.37 $1.58 Million - $1.9 Million
19,510 Added 311.41%
25,775 $2.13 Million
Q1 2024

May 13, 2024

BUY
$71.24 - $85.35 $446,318 - $534,717
6,265 New
6,265 $535,000

Others Institutions Holding HAE

About HAEMONETICS CORP


  • Ticker HAE
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 51,316,500
  • Market Cap $4.54B
  • Description
  • Haemonetics Corporation, a healthcare company, provides medical products and solutions. It operates through three segments: Plasma, Blood Center, and Hospital. The company offers automated plasma collection devices, related disposables, and software, including NexSys PCS and PCS2 plasmapheresis equipment and related disposables and intravenous s...
More about HAE
Track This Portfolio

Track Harbor Capital Advisors, Inc. Portfolio

Follow Harbor Capital Advisors, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Harbor Capital Advisors, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Harbor Capital Advisors, Inc. with notifications on news.